NNNN

ANBIO BIOTECHNOLOGY

NNNN·G0367B105·US·Common Stock·Healthcare - Medical Instruments & Supplies

NNNN (ANBIO BIOTECHNOLOGY) is held by 8 institutional investors as of Q2 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($366,550), BANK OF AMERICA CORP /DE/ ($183,974), BNP PARIBAS FINANCIAL MARKETS ($161,778). Net institutional sentiment: Mixed.

8
Holders
$982,257
Total Value
67% (9)
Consensus
6 buying - 3 selling
13F: Insider & Congress: Updated regularly
NNNN

Smart Money Verdict

View all
Loading verdict
Held by 8 funds

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders none · Activists none · Congress none

No recent insider, activist, or congressional trades for NNNN.

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
26,736(+3.8%)$366,5500.0%-52.88%
17
New
13,419$183,9740.0%-43.69%
35
Increased
11,800(+13.5%)$161,7780.0%-66.13%
25
New
11,502$157,6920.0%-43.69%
31
Decreased
7,231(-1.5%)$99,1370.0%-66.65%
0
Decreased
828(-86.9%)$11,3520.0%-68.44%
0
New
77$1,0560.0%-43.69%
17
New
53$7180.0%-43.69%
17
Exited
0(-100.0%)$2,5690.0%-56.07%
0
NNNNNNNNANBIO BIOTECHNOLOGY

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used